Abstract:Rationale: Recurrent and metastatic cancers often undergo a period of dormancy, which is closely associated with cellular quiescence, a state whereby cells exit the cell cycle and are reversibly arrested in G0 phase. Curative cancer treatment thus requires therapies that either sustain the dormant state of quiescent cancer cells, or preferentially, eliminate them. However, the mechanisms responsible for the survival of quiescent cancer cells remain obscure. Methods: Dual genome-editing was carried out using a CRISPR/Cas9-based system to label endogenous p27 and Ki67 with the green and red fluorescent proteins EGFP and mCherry, respectively, in melanoma cells. Analysis of transcriptomes of isolated EGFP-p27highmCherry-Ki67low quiescent cells was conducted at bulk and single cell levels using RNA-sequencing. The extracellular acidification rate and oxygen consumption rate were measured to define metabolic phenotypes. SiRNA and inducible shRNA knockdown, chromatin immunoprecipitation and luciferase reporter assays were employed to elucidate mechanisms of the metabolic switch in quiescent cells. Results: Dual labelling of endogenous p27 and Ki67 with differentiable fluorescent probes allowed for visualization, isolation, and analysis of viable p27highKi67low quiescent cells. Paradoxically, the proto-oncoprotein c-Myc, which commonly drives malignant cell cycle progression, was expressed at relatively high levels in p27highKi67low quiescent cells and supported their survival through promoting mitochondrial oxidative phosphorylation (OXPHOS). In this context, c-Myc selectively transactivated genes encoding OXPHOS enzymes, including subunits of isocitric dehydrogenase 3 (IDH3), whereas its binding to cell cycle progression gene promoters was decreased in quiescent cells. Silencing of c-Myc or the catalytic subunit of IDH3, IDH3α, preferentially killed quiescent cells, recapitulating the effect of treatment with OXPHOS inhibitors. Conclusion: These results establish a rigorous experimental system for investigating cellular quiescence, uncover the high selectivity of c-Myc in activating OXPHOS genes in quiescent cells, and propose OXPHOS targeting as a potential therapeutic avenue to counter cancer cells in quiescence.

Dynamic p21-dependency during quiescence arrest unveiled by a rapid p21 depletion system

Hematopoietic Stem Cell Quiescence Maintained by P21 Cip1/waf1

DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression

Pro-survival roles for p21(Cip1/Waf1) in Non-Small Cell Lung Cancer

Graded Regulation of Cellular Quiescence Depth Between Proliferation and Senescence by a Lysosomal Dimmer Switch.

p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling

Deubiquitylation And Stabilization Of P21 By Usp11 Is Critical For Cell-Cycle Progression And Dna Damage Responses

Examination of the expanding pathways for the regulation of p21 expression and activity

Reciprocal regulation of p21 and Chk1 controls the Cyclin D1-RB pathway to mediate senescence onset after DNA damage-induced G2 arrest

A non-canonical CDK, Pho85 regulates the restart of the cell-cycle following stress

Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells

From rest to repair: Safeguarding genomic integrity in quiescent cells

p21-containing cyclin kinases exist in both active and inactive states.

Stress-induced reversible cell-cycle arrest requires PRC2/PRC1-mediated control of mitophagy in Drosophila germline stem cells and human iPSCs

3199 – P21/ZBTB18 REPRESS THE EXPRESSION OF CKIT TO REGULATE THE SELF-RENEWAL OF HEMATOPOIETIC STEM CELLS

P21 Disrupts the Interaction Between Cdk2 and the E2F-p130 Complex.

P57kip2 is a Master Regulator of Human Adipose Derived Stem Cell Quiescence and Senescence

Radiation-induced cell cycle arrest compromised by p21 deficiency

p21: A Two-Faced Genome Guardian

A Lysosomal Dimmer Switch Regulates Cellular Quiescence Depth